Print Page   |   Sign In   |   Join MAA
News & Press: News

Shingles Prevention Update: heads up about a new vaccine under study

Wednesday, April 5, 2017   (0 Comments)
Posted by: David Waldrep
Share |

By Sandra Adamson Fryhofer MD 

 

 If you have had chicken pox, you’re at risk for shingles.  Risk increases with age (starting at 50).  ACIP says everyone 60 and older needs vaccination, unless there’s a contraindication.  The only zoster vaccine currently available (brand name Zostavax) is a live virus vaccine so it can’t be given to people with immune system problems or to anyone who’s pregnant.  Zostavax overall cuts the risk of getting shingles in half.  There’s a new adjuvant herpes zoster subunit vaccine (HZ/su) under study.  It’s not yet available; so it is not mentioned in the schedule, but a recent study in NEJM  (http://www.nejm.org/doi/full/10.1056/NEJMoa1501184#t=articlesays it cuts risk of shingles by more than 97%.  It is likely zoster vaccination recommendations may change if or when this new vaccine is licensed by FDA. 


Association Management Software Powered by YourMembership  ::  Legal